Robert J. Alpern - 31 Mar 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Robert J. Alpern by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
31 Mar 2022
Transactions value $
$7,812
Form type
4
Filing time
01 Apr 2022, 17:21:05 UTC
Previous filing
04 Jan 2022
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $7.81K +66 +0.77% $118.36 8.69K 31 Mar 2022 Common Shares 66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.